
OPTION CARE HEALTH INC
OPCHNASDAQTrading Snapshot
- Day Range
- $23.85 β $24.23
- 52-Week Range
- $18.01 β $36.80
- Volume
- $3.56B
- Avg Volume
- $2.61B
- Shares Outstanding
- 149.8M
- Next Earnings
- Oct 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $5.65B
- Last Q Revenue
- $1.44B
- P/E Ratio
- 17.4
- P/S Ratio
- 0.6x
- EPS (TTM)
- $1.32
- Dividend Yield
- β
Why Investors Own OPCH
- βHigh-growth profile β revenue up +10.1% YoY with expanding US Equity exposure.
- βHealthy economics β 52% gross margin and 29% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About OPTION CARE HEALTH INC
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
OPTION CARE HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift OPCH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
OPTION CARE HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.